Is there a generic version of Dasatinib (Startax) in India? How much?

Dasatinib (Dasatinib) is a targeted therapy drug, a tyrosine kinase inhibitor, mainly used to treat patients with chronic myelogenous leukemia (CML) and some acute lymphoblastic leukemia (ALL).

Dasatinib (Dasatinib) is now on the market in China and has been included in the medical insurance system. Patients can purchase it directly in China, with the price ranging from RMB 4,000 to RMB 5,000. For specific drug pricing and medical insurance reimbursement ratios, patients are asked to go to the pharmacy of their local hospital for detailed consultation.

In addition, the price of foreignDasatinib (Stardas) generic drugs is relatively more affordable, usually only a few hundred yuan, which has a significant price advantage over domestic ones. Among them, Indian generic drugs are generic drugs that are officially marketed abroad. The specifications are 50mg*60 and the price is around 500 to 600.

It is worth noting that the ingredients of original drugs marketed in China and foreign generic drugs are highly consistent. Therefore, when patients choose drugs, they can make reasonable choices based on their actual situation and economic conditions.

The main function of dasatinib is to inhibit the kinase activity of the BCR-ABL fusion protein, which is a common disease-causing gene in CML and some ALL patients. BCR-ABLThe abnormal kinase activity of the fusion protein leads to abnormal cell proliferation and survival signaling. Dasatinib (Startase) prevents the growth and spread of leukemia cells by inhibiting this process.

The dose of dasatinib is usually adjusted based on the patient's condition and response to treatment, with a typical starting dose ranging from 100 mg to 140 mg per day. During the treatment process, the doctor may gradually adjust the dosage according to the patient's specific condition to achieve the best therapeutic effect.

Dasatinib (Startase) It may cause some adverse reactions, common ones include: nausea, vomiting, diarrhea, fatigue, edema, rash, headache, joint pain, etc. Some patients may also experience serious adverse reactions such as bone marrow suppression and bleeding tendencies, which require prompt medical treatment.